The company's first product is the Full Sense™ Bariatric Device. It is placed via endoscopy in the distal esophagus and proximal stomach. By applying pressure to this area it causes satiety without the need for the presence of food. The Full Sense™ Bariatric Device has undergone successful preclinical evaluations and has completed it's first clinical evaluation with over 28% excess body weight loss in 6 1/2 weeks. The device is easily removed via endoscopy.  March 2010: Thirteen successful implant procedures performed in Cancun Mexico as part of a planned 50 patient study. Full Sense™ Bariatric Device (Get more information at the Full Sense Device Blog) Sentinel Group is a medical device development company formed to commercialize patents owned by its principals and to assist physician inventors in commercializing their ideas. Sentinel Group, 6223 Cascade Pointe Dr, Grand Rapids, MI 49546 |
|
|
Home |
